Updated clinical classification of pulmonary hypertension

G Simonneau, IM Robbins, M Beghetti… - Journal of the American …, 2009 - jacc.org
The aim of a clinical classification of pulmonary hypertension (PH) is to group together
different manifestations of disease sharing similarities in pathophysiologic mechanisms …

Pulmonary arterial hypertension

D Montani, S Günther, P Dorfmüller, F Perros… - Orphanet journal of rare …, 2013 - Springer
Pulmonary arterial hypertension (PAH) is a chronic and progressive disease leading to right
heart failure and ultimately death if untreated. The first classification of PH was proposed in …

ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre

J Hurdman, R Condliffe, CA Elliot… - European …, 2012 - Eur Respiratory Soc
Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists
reflecting the spectrum of disease across the five diagnostic groups encountered in a …

Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature

MR Pokeerbux, J Giovannelli, L Dauchet… - Arthritis research & …, 2019 - Springer
Background Data on survival and prognosis factors in incident cohorts are scarce in
systemic sclerosis (SStc). To describe survival, standardized mortality ratio (SMR), and …

Systemic sclerosis: an update in 2016

AC Desbois, P Cacoub - Autoimmunity reviews, 2016 - Elsevier
Systemic sclerosis (SSc) is a chronic immune disorder of unknown origin, dominated by
excessive fibrosis responsible for cutaneous and pulmonary fibrosis, and by vascular …

[HTML][HTML] Cardiac manifestations in systemic sclerosis

S Lambova - World journal of cardiology, 2014 - ncbi.nlm.nih.gov
Primary cardiac involvement, which develops as a direct consequence of systemic sclerosis
(SSc), may manifest as myocardial damage, fibrosis of the conduction system, pericardial …

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic …

Y Allanore, C Meune, MC Vonk, P Airo… - Annals of the …, 2010 - ard.bmj.com
Objectives: To measure the prevalence of, and factors associated with, left ventricular (LV)
dysfunction in systemic sclerosis (SSc). Methods: The EUSTAR database was first searched …

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

AL Hachulla, D Launay, V Gaxotte… - Annals of the …, 2009 - ard.bmj.com
Objectives: To assess the prevalence and patterns of cardiac abnormalities as detected by
cardiac magnetic resonance imaging (MRI) in systemic sclerosis (SSc). Methods: Fifty-two …

Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis

AH Tennøe, K Murbræch, JC Andreassen… - Journal of the American …, 2018 - jacc.org
Background: Primary cardiac affection is common and is a major cause of death in systemic
sclerosis (SSc), but there are knowledge gaps regarding the effect of cardiac dysfunction on …

Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors

L Farkas, J Gauldie, NF Voelkel… - American journal of …, 2011 - atsjournals.org
Idiopathic pulmonary fibrosis (IPF) is a disabling disease of the lung parenchyma,
characterized by progressive accumulation of scar tissue and myofibroblast activation after …